Results 111 to 120 of about 94,378 (168)
Toxicidade de fármacos nitrofurânicos
Durante o planejamento estrutural de novos fármacos, é possível prever a infl uência de grupamentos específi cos na atividade farmacológica. Entre estes, encontrase o grupo nitro, que possui potencial atividade antimicrobiana, estando presente em ...
P. L. BOSQUESI +5 more
core
[Determinants of bleeding risk in anticoagulated patients in primary care: A retrospective observational study]. [PDF]
Ciorba FR +2 more
europepmc +1 more source
Técnicas QSAR en el diseño de fármacos
Técnicas QSAR en el diseño de ...
Álvarez Builla, J., Pastor, M.
core
[Study on the factors influencing treatment adherence in patients with chronic multimorbidity]. [PDF]
Zarza-Arribas M +5 more
europepmc +1 more source
La glicobiología: un camino para producir fármacos
La glicobiología: un camino para producir ...
Cabezas Fernández del Campo, Jose Antonio
core
IgA nephropathy: evolving treatment strategies. [PDF]
Mastroianni-Kirsztajn G +2 more
europepmc +1 more source
[Anti-obesity drugs and potential changes in the epidemiology of this condition and in cardiovascular risk factors]. [PDF]
Cuatrecasas G.
europepmc +1 more source
[Adverse reactions of GLP-1 analogues when used to treat obesity in non-diabetic patients]. [PDF]
Barcelo Colomer ME, Fernández Liz E.
europepmc +1 more source
[Spasticity in Multiple Sclerosis: 2026 Expert Consensus]. [PDF]
Oreja-Guevara C +13 more
europepmc +1 more source

